Periodic monitoring Active

Key facts

  • In August 2024, 27 countries reported measles data to The European Surveillance System (TESSy), with 786 cases reported by 18 countries. Nine countries reported zero cases.
  • Through its epidemic intelligence activities, ECDC has identified 199 new measles cases in 11 EU/EEA countries reported since the last monthly update in September.
  • In 2024, 19 measles-related deaths have been reported in Romania (18) and Ireland (1).
  • Overall in the EU/EEA, over the last 12 months, there has been high measles activity; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks and others have reported no sustained or very low transmission.
  • Relevant updates outside the EU/EEA are available for Switzerland, the United Kingdom (UK), countries in the Western Balkan and WHO Regions.

Overview

In August 2024, 27 countries reported measles data to The European Surveillance System (TESSy), with 786 cases reported by 18 countries. Nine countries reported zero cases.

In the most recent 12-month period, from 1 September 2023 to 31 August 2024, 30 EU/EEA Member States reported a total of 18 449 cases of measles, 14 241 (77.2%) of which were laboratory confirmed. During this 12-month period, two countries (Latvia and Liechtenstein) reported zero cases. The highest number of cases were reported by Romania (14 347), Italy (897), Belgium (606), Austria (532) and Germany (516). The highest notification rates were observed among infants under one year of age (590.9 cases per million) and children aged 1-4 years (348.6 cases per million). Thirteen deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC during the 12-month period by Romania (12) and Ireland (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases and the Measles and Rubella monthly report.

Complementary epidemic intelligence surveillance, with data collection conducted on 9 October 2024 from official public and media sources, detected 199 new suspected and/or confirmed measles cases that were reported since the last monthly update in September. New cases were reported in 11 EU/EEA countries : Austria (new: 2; total: 504), Bulgaria (new: 6; total: 26), Czechia (new: 3, total: 33), Germany (new: 78; total: 698), Hungary (new: 4, total: 29), Ireland (new: 29; total: 135, including 1 death), Italy (new: 57; total: 864), Netherlands (new: 7; total: 163), Norway (new: 1; total: 11), Poland (new: 1; total: 262), Sweden (new: 11; total: 37). Overall, 19 measles-related deaths have been reported in the EU/EEA in 2024, in Romania (18) and Ireland (1).

Relevant updates for outside the EU/EEA are available for Switzerland, the UK, and countries in the Western Balkan and WHO Regions.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with epidemic intelligence updates since last month:

Austria reported 504 confirmed measles cases in 2024 as of 8 October 2024, an increase of two cases since 10 September 2024. Of the 490 cases for which hospitalisation information was available, 106 individuals (22%) were hospitalised, including four in the intensive care unit. All regions reported at least one case of measles in 2024, with most of the cases reported in Lower Austria (117, 23%) and Tyrol (88, 17%).

 

Bulgaria reported 26 measles cases in 2024 and as of 8 October 2024, an increase of six cases since 5 August 2024. No cases were reported for the same period of the previous year.

 

Czechia reported 33 measles cases in 2024 and as of 3 October 2024, an increase of three cases since the last monthly measles report.

Germany reported 698 confirmed and suspected measles cases in 2024 (data as of 10 October 2024), an increase of 78 cases since 11 September 2024.

Hungary reported 29 measles cases as of 7 October 2024, an increase of four cases since 3 August 2024.

Ireland has reported 135 confirmed measles cases as of 8 October 2024, an increase of 29 cases since 9 September 2024. In addition, 20 cases are currently under investigation. Outbreaks have been reported across all six Health Service Executive (HSE) regions.

Italy reported 864 measles cases between 1 January and 31 August 2024 and as of 16 September 2024. This is an increase of 57 cases since 31 July 2024. Cases have been reported from 17/21 regions, mostly in unvaccinated individuals (90%). At a national level, the incidence in 2024 is 22 cases per million inhabitants.

 

Netherlands reported 163 measles cases in 2024 and as of 18 September 2024, an increase of seven cases since 21 August 2024.

Norway reported 11 cases as of 9 October 2024, an increase of one case since 11 September 2024.

 

Poland reported 262 measles cases from January to 30 September 2024, an increase by one case since 31 August 2024.

 

Sweden reported 37 cases in 2024 as of 9 October 2024, an increase of 11 cases since of 11 September 2024.

Relevant epidemiological summary for countries outside the EU/EEA:

Switzerlandreported 99 cases in 2024 and as of 30 September 2024, an increase of five cases since 2 September 2024.

United Kingdom has reported several outbreaks of measles in 2024. As of 26 September, 2 562 measles cases have been confirmed in England in 2024, an increase of 175 cases since 29 August. In Northern Ireland, 20 cases were confirmed between January and 2 October, an increase of two cases since 1 September 2024. In Scotland there have been 17 laboratory-confirmed measles cases in 2024 and as of 2 October 2024. As of 31 July 2024, Wales confirmed 17 measles cases.

Western Balkans: Several countries continue to report measles cases.

Bosnia and Herzegovina

The Republic of Srpska has reported 309 measles cases as of 4 October 2024, an increase by one case since 6 September 2024. As of 9 October 2024, the Federation of Bosnia and Herzegovina notified 7 228 measles cases,

including one death in 2024, an increase of 39 cases since 11 September 2024. As of 9 October 2024, Brcko district reported 194 measles cases, an increase of 84 cases since 8 August 2024. On 4 October 2024, the Brcko district government announced an end to the measles epidemic.

Serbia reported 432 measles cases as of 2 October 2024, an increase of 84 cases since 31 August 2024.

Montenegro reported 27 measles cases as of 30 September 2024, an increase of two cases since 9 September 2024.

Summary of measles cases reported by WHO regional offices (as of 16 September 2024)

WHO Regional Office for Europe (WHO/EUROPE) reported 95 204 measles cases in 2024. The five non-EU/EEA countries reporting the most measles cases were: Kazakhstan (27 760), Azerbaijan (16 675), Russian Federation (14 751), Kyrgyzstan (12 587), and the United Kingdom (2 398).

 

The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

 

WHO Regional Office for Africa (WHO AFRO) has reported 67 976 measles cases in 2024. The highest numbers of cases were reported from Ethiopia (26 493), Nigeria (8 243), Burkina Faso (6 457), Cote d’Ivoire (6 048) and the Democratic

Republic of the Congo (4 149).

 

WHO Regional Office for the Americas (WHO PAHO) has reported 342 measles cases in 2024. Most cases (238) were reported in the United States.

WHO Regional Office for the Eastern Mediterranean (WHO EMRO) has reported 80 607 measles cases in 2024. The highest numbers of cases were reported from Iraq (30 889), Pakistan (21 070), Yemen (17 730), Afghanistan (7 023) and Somalia (1 119).

WHO Regional Office for South-East Asia (WHO SEARO) has reported 24 541 measles cases in 2024. The highest numbers of cases were reported from India (16 934), Indonesia (4 145), Thailand (2 694), Sri Lanka (242), and Nepal (201).

WHO Regional Office for the Western Pacific (WHO WPRO) has reported 7 137 measles cases in 2024. The following five countries reported the most cases: the Philippines (3 346), Malaysia (2 647), China (665), Viet Nam (347), and Republic of Korea (47).

ECDC assessment

The overall number of measles cases in the EU/EEA has been steadily increasing since June 2023. Measles cases may continue to increase in the EU/EEA in the coming months. This is due to reported sub-optimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries (<95% in many of these countries), as well as a high probability of importation from areas experiencing high circulation. In addition, the majority of recently reported cases have acquired the disease within the reported country through community/local transmission, indicating a higher probability of being exposed to the virus within the EU/EEA than in previous months.

As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance, and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of sub-optimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies, to reduce inequalities in vaccine uptake.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response' published in February 2024 and the conclusions of that remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.  

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.

Latest updates for this event

View all